Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory
Pathology · 2023-06 · 55 (4) · 538-542
DOI: 10.1016/j.pathol.2023.01.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology, 2023-06. Verfasst von Amelia Cecchin und 3 weiteren Autor:innen. Beteiligte Einrichtung: SA Pathology, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Autoimmune Diseases, Diabetes Mellitus, Type 1, Nervous System Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SA Pathology, Adelaide, SA, Australia.
- SA Pathology, Adelaide, SA, Australia; Royal Adelaide Hospital, Adelaide, SA, Australia.
- SA Pathology, Adelaide, SA, Australia; Royal Adelaide Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia. Electronic address: Pravin.Hissaria@health.sa.gov.au.
Zitieren
APA
Cecchin, A., Reynolds, C., Ali, S., & Hissaria, P. (2023). Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory. Pathology, 55(4), 538-542. https://doi.org/10.1016/j.pathol.2023.01.010
Vancouver
Cecchin A, Reynolds C, Ali S, Hissaria P. Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory. Pathology. 2023;55(4):538-542. doi:10.1016/j.pathol.2023.01.010
BibTeX
@article{Cecchin2023,
author = {Cecchin, Amelia and Reynolds, Claire and Ali, Syed and Hissaria, Pravin},
title = {Evaluation of glutamic acid decarboxylase (GAD) 65 antibody detection methods for neurological and diabetic investigation in an Australian diagnostic laboratory},
journal = {Pathology},
year = {2023},
volume = {55},
number = {4},
pages = {538--542},
doi = {10.1016/j.pathol.2023.01.010}
}
EUVIMED